Log In
Print this Print this

Anti-C3 protease

  Manage Alerts
Collapse Summary General Information
Company Catalyst Biosciences Inc.
DescriptionAnti-C3 protease
Molecular Target Complement 3 (C3)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard IndicationAge-related macular degeneration (AMD)
Indication DetailsTreat age-related macular degeneration (AMD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today